In contrast to the acute myelogenous leukemia (AML) patient data, where elevated MSI2 expression correlates with FLT3-ITD/NPM1 mutations5, 8, 9, 11, MDS patients do not typically harbour these mutations. The gene discussed is NPM1; the disease is acute myeloid leukemia.